Search alternatives:
point decrease » point increase (Expand Search)
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 67,101 - 67,120 results of 125,024 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( a ((mean decrease) OR (point decrease)) ))', query time: 1.44s Refine Results
  1. 67101
    Image_10_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.TIF

    Image_10_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis... by Yaobin Ouyang (6004142)

    Published 2022
    “…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
    Save to List
    Saved in:
  2. 67102
    Image_4_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.TIF

    Image_4_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.... by Yaobin Ouyang (6004142)

    Published 2022
    “…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
    Save to List
    Saved in:
  3. 67103
    Image_6_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.TIF

    Image_6_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.... by Yaobin Ouyang (6004142)

    Published 2022
    “…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
    Save to List
    Saved in:
  4. 67104
    Image_9_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.TIF

    Image_9_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.... by Yaobin Ouyang (6004142)

    Published 2022
    “…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
    Save to List
    Saved in:
  5. 67105
    Image_12_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.TIF

    Image_12_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis... by Yaobin Ouyang (6004142)

    Published 2022
    “…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
    Save to List
    Saved in:
  6. 67106
    Image_3_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.TIF

    Image_3_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.... by Yaobin Ouyang (6004142)

    Published 2022
    “…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
    Save to List
    Saved in:
  7. 67107
    Image_1_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.TIF

    Image_1_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.... by Yaobin Ouyang (6004142)

    Published 2022
    “…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
    Save to List
    Saved in:
  8. 67108
    Image_8_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.TIF

    Image_8_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.... by Yaobin Ouyang (6004142)

    Published 2022
    “…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
    Save to List
    Saved in:
  9. 67109
    Image_2_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.TIF

    Image_2_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.... by Yaobin Ouyang (6004142)

    Published 2022
    “…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
    Save to List
    Saved in:
  10. 67110
    Image_11_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.TIF

    Image_11_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis... by Yaobin Ouyang (6004142)

    Published 2022
    “…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
    Save to List
    Saved in:
  11. 67111
    Table_1_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.docx

    Table_1_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.... by Yaobin Ouyang (6004142)

    Published 2022
    “…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
    Save to List
    Saved in:
  12. 67112
    Table_2_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.DOC

    Table_2_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.... by Yaobin Ouyang (6004142)

    Published 2022
    “…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
    Save to List
    Saved in:
  13. 67113
    Image_7_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.TIF

    Image_7_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.... by Yaobin Ouyang (6004142)

    Published 2022
    “…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
    Save to List
    Saved in:
  14. 67114
    Image_13_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.TIF

    Image_13_Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis... by Yaobin Ouyang (6004142)

    Published 2022
    “…</p>Results<p>Five studies with 2,110 H. pylori-infected patients were enrolled. …”
    Save to List
    Saved in:
  15. 67115
    Forty-eight ClinVar “pathogenic” alleles enriched in AJ.

    Forty-eight ClinVar “pathogenic” alleles enriched in AJ. by Manuel A. Rivas (228371)

    Published 2018
    Save to List
    Saved in:
  16. 67116
    Cohesin depletion reduces long-range interactions between PRE-containing regions in the <b><i>invected-engrailed</i></b><b> locus in BG3 cells.</b>

    Cohesin depletion reduces long-range interactions between PRE-containing regions in the <b><i>invected-engrailed</i></b><b> locus in BG3 cells.</b> by Cheri A. Schaaf (144616)

    Published 2013
    “…Anchors <b>a</b> and <b>d</b>, shown in the top and bottom panels, are outside of the complex and show high local interactions but do not interact with points inside the complex. …”
    Save to List
    Saved in:
  17. 67117
    Supplementary Material for: How Social Exclusion, Embitterment, and Conspiracy Beliefs Mediate Individual’s Intention to Vaccination against COVID-19: Results from a Moderated Serial Mediation Analysis

    Supplementary Material for: How Social Exclusion, Embitterment, and Conspiracy Beliefs Mediate Individual’s Intention to Vaccination against COVID-19: Results from a Moderated Seri... by Koroma D. (11932601)

    Published 2022
    Save to List
    Saved in:
  18. 67118
    Supplementary Material for: A Case of Granulocyte-Colony-Stimulating Factor-Producing Non-Small Cell Lung Cancer under Steroid Treatment and with Poor Performance Status that responded to Pembrolizumab

    Supplementary Material for: A Case of Granulocyte-Colony-Stimulating Factor-Producing Non-Small Cell Lung Cancer under Steroid Treatment and with Poor Performance Status that respo... by Egusa H. (19645753)

    Published 2024
    Save to List
    Saved in:
  19. 67119
    Data_Sheet_1_Branebrutinib (BMS-986195), a Bruton’s Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents.PDF

    Data_Sheet_1_Branebrutinib (BMS-986195), a Bruton’s Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agent... by Chung-Pu Wu (66107)

    Published 2021
    Save to List
    Saved in:
  20. 67120
    Rapid Environmental Change over the Past Decade Revealed by Isotopic Analysis of the California Mussel in the Northeast Pacific

    Rapid Environmental Change over the Past Decade Revealed by Isotopic Analysis of the California Mussel in the Northeast Pacific by Catherine A. Pfister (203701)

    Published 2011
    “…A lack of instrumentation prior to the 1990s means that we have no indication whether these carbon cycle changes have precedence or are a response to recent anthropogenic CO<sub>2</sub> inputs. …”
    Save to List
    Saved in:

Search Tools: